Back to search

Cellular Distribution of Phosphorothioate Oligonucleotide Following Intravenous Administration in Mice

Data up to Jan 2025

Published1998
Citations41
References35

Total Citations Per Year

Abstract

References (35)

CpG motifs in bacterial DNA trigger direct B-cell activation

1995 • 3,543 citations

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

1996 • 1,498 citations

Macrophages ingest and are activated by bacterial DNA.

1996 • 579 citations

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.

1991 • 551 citations

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

1989 • 510 citations

Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

1995 • 308 citations

Immune Activation by Bacterial DNA: A New Genetic Code

1996 • 304 citations

Antisense oligonucleotides: towards clinical trials

1996 • 268 citations

Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.

1994 • 252 citations

Complement Activation and Hemodynamic Changes Following Intravenous Administration of Phosphorothioate Oligonucleotides in the Monkey

1994 • 240 citations

Comparison of Cellular Binding and Uptake of Antisense Phosphodiester, Phosphorothioate, and Mixed Phosphorothioate and Methylphosphonate Oligonucleotides

1993 • 231 citations

Effect of different chemically modified oligodeoxynucleotides on immune stimulation

1996 • 171 citations

Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues.

1997 • 147 citations

In vivo fate of phosphorothioate antisense oligodeoxynucleotides: predominant uptake by scavenger receptors on endothelial liver cells

1997 • 147 citations

Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.

1996 • 140 citations

Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302).

1997 • 137 citations

Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects*

1995 • 130 citations

Pharmacokinetics, metabolism, and elimination of a 20-mer phosphorothioate oligodeoxynucleotide (cgp 69846a) after intravenous and subcutaneous administration

1997 • 121 citations

Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys

1997 • 119 citations

In VivoToxicological Effects ofrelA Antisense Phosphorothioates in CD-1 Mice

1994 • 108 citations

A pharmacokinetic evaluation of 14C-labeled afovirsen sodium in patients with genital warts

1994 • 79 citations

Mixed Backbone Oligonucleotides: Improvement in Oligonucleotide-induced Toxicity In Vivo

1998 • 78 citations

Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice.

1994 • 71 citations

Large-Scale Synthesis, Purification, and Analysis of Oligodeoxynucleotide Phosphorothioates

1994 • 66 citations

Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors

1994 • 65 citations

Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation

1996 • 62 citations

Disposition of oligonucleotides in isolated perfused rat kidney: involvement of scavenger receptors in their renal uptake.

1996 • 58 citations

Comparison of the toxicity profiles of ISIS 1082 and ISIS 2105, phosphorothioate oligonucleotides, following subacute intradermal administration in Sprague-Dawley rats

1997 • 41 citations

Pharmacology and toxicology of phosphorothioate oligonucleotides in the mouse, rat, monkey and man

1995 • 29 citations

One-step labelling of oligonucleotides with fluoresceine during automated synthesis

1990 • 28 citations

Binding of Antisense Phosphorothioate Oligonucleotides to Murine Lymphocytes Is Lineage Specific and Inducible

1992 • 27 citations

Distribution of the Cellular Uptake of Phosphorothioate Oligodeoxynucleotides in the Rat Kidney in vivo

1997 • 23 citations

Repeat-dose toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after bolus intravenous administration to cynomolgus monkeys.

1996 • 15 citations

HIV-1revAntisense Phosphorothioate Oligonucleotide Binding to Human Mononuclear Cells Is Cell Type Specific and Inducible

1994 • 8 citations

Pharmacokinetics and distribution of a 33P-labeled anti-human immunodeficiency virus oligonucleotide (AR177) after single- and multiple-dose intravenous administration to rats.

1997 • 5 citations

Cited By (0)

Loading...
Cellular Distribution of Phosphorothioate Oligonucleotide Following Intravenous… (1998) – Antisense and Nucleic Acid Drug Development | Metascience Observatory Explorer